Treatment Options for Metastatic Breast Cancer

Metastatic breast cancer (also called stage IV or advanced breast cancer) is not a specific type of breast cancer. Stage IV or metastatic breast cancer is known as the most leading stage of breast cancer. Stage IV breast cancer is breast cancer that has progressed beyond the breast and surrounding lymph nodes to other areas […]

Tecvayli: Approved by the FDA for blood cancer treatment

The US FDA granted accelerated approval on October 25, 2022, to the drug teclistamab-cqyv, which is sold under the brand name Tecvayli for the treatment of relapsed or refractory multiple myeloma who have received at least four prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent and an anti-CD38 monoclonal antibody. Tecvayli is […]